Allspring Global Investments Holdings, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$19,734,921
+3.5%
220,305
-1.7%
0.04%
+16.7%
Q2 2023$19,071,530
-23.7%
224,002
-25.9%
0.03%
-26.8%
Q1 2023$25,005,312
-0.5%
302,179
-5.4%
0.04%
-4.7%
Q4 2022$25,135,517
-1.1%
319,587
-6.9%
0.04%
-4.4%
Q3 2022$25,417,000
+4.2%
343,337
-8.3%
0.04%
+9.8%
Q2 2022$24,391,000
+15.8%
374,217
+12.3%
0.04%
+51.9%
Q1 2022$21,063,000
+16.6%
333,173
-2.1%
0.03%
+35.0%
Q4 2021$18,057,000340,4430.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders